Anti-SIGLEC15 ADCC Enhanced Antibody (AB-25E9) is an ADCC enhanced antibody produced by our Afuco™ platform. AB-25E9 is a humanized IgG2 that inhibits the function of Siglec-15 and has tremendous potential as a novel antiresorptive for the treatment of patients with acute bone loss.
Figure 1 illustrate the inhibition of the differentiation of human osteoclasts upon treatment with increasing concentrations of anti-Siglec-15 IgG2 chimeric monoclonal antibodies 25B8, 25E6, 25E9 or of a control IgG2 antibody. After treatment, the osteoclasts were stained for TRAP expression.
Figure 2 illustrate the inhibition of the differentiation of mouse osteoclasts upon treatment with increasing concentrations of anti-Siglec-15 IgG2 chimeric monoclonal antibodies 25B8, 25E6, 25D8 or of a control IgG2. After treatment, the osteoclasts were stained for TRAP expression.
Figure 3 illustrate the ability of the 25E9 candidate antibody that is specific for Siglec-15 to inhibit the bone resorbing activity of osteoclasts in comparison with the 25D8 antibody or controls.
A: cells treated with M-CSF; B: cells treated with M-CSF and RANKL; C: cells treated with the 25D8 antibody at 1 mg/ml; D: cells treated with the 25D8 antibody at 10 mg/ml; E: cells treated with control IgG at 1 mg/ml; F: cells treated with control IgG at 10 mg/ml; G: cells treated with the 25E9 antibody at 1 mg/ml; H: cells treated with the 25E9 antibody at 10 mg/ml).
This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:
• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production
See more details about Hi-Affi™ recombinant antibody benefits.
Download resources about recombinant antibody development and antibody engineering to boost your research.
CAT | Product Name | Application | Type |
---|---|---|---|
MHH-904-S(P) | Recombinant Human Anti-human SIGLEC15 Antibody scFv Fragment | IP, IF, Biosensors, FuncS | scFv |
HPAB-J0223-YC-S(P) | Rat Anti-SIGLEC15 Recombinant Antibody; scFv Fragment (HPAB-J0223-YC-S(P)) | ELISA, Inhib (0.3 µg/mL to 3 µg/mL), FuncS | Rat scFv |
HPAB-J0224-YC-S(P) | Human Anti-SIGLEC15 Recombinant Antibody; scFv Fragment (HPAB-J0224-YC-S(P)) | ELISA, Inhib (0.3 µg/mL to 3 µg/mL), FuncS | Rat scFv |
HPAB-J0225-YC-S(P) | Human Anti-SIGLEC15 Recombinant Antibody; scFv Fragment (HPAB-J0225-YC-S(P)) | ELISA, Inhib, FuncS | Humanized scFv |
HPAB-J0226-YC-S(P) | Human Anti-SIGLEC15 Recombinant Antibody; scFv Fragment (HPAB-J0226-YC-S(P)) | ELISA, Inhib, FuncS | Humanized scFv |
CAT | Product Name | Application | Type |
---|---|---|---|
TAB-568CL | Human Anti-SIGLEC15 Recombinant Antibody (TAB-568CL) | ELISA | Human IgG2 |
CAT | Product Name | Application | Type |
---|---|---|---|
TAB-447CT | Human Anti-Siglec15 Recombinant Antibody (TAB-447CT) | WB, ELISA, FC | Human IgG |
TAB-448CT | Human Anti-Siglec15 Recombinant Antibody (TAB-448CT) | WB, ELISA, FC | Human IgG |
TAB-447CT-S(P) | Human Anti-Siglec15 Recombinant Antibody; scFv Fragment (TAB-447CT-S(P)) | WB, ELISA, FC | Human scFv |
TAB-447CT-F(E) | Human Anti-Siglec15 Recombinant Antibody; Fab Fragment (TAB-447CT-F(E)) | WB, ELISA, FC | Human Fab |
TAB-448CT-F(E) | Human Anti-Siglec15 Recombinant Antibody; Fab Fragment (TAB-448CT-F(E)) | WB, ELISA, FC | Human Fab |
CAT | Product Name | Application | Type |
---|---|---|---|
TAB-441CT-F(E) | Chimeric Anti-Siglec15 Recombinant Antibody; Fab Fragment (TAB-441CT-F(E)) | ELISA, FC, BL | Chimeric antibody (mouse/human) |
TAB-442CT-F(E) | Chimeric Anti-Siglec15 Recombinant Antibody; Fab Fragment (TAB-442CT-F(E)) | ELISA, FC, BL | Chimeric antibody (mouse/human) |
TAB-443CT-F(E) | Chimeric Anti-Siglec15 Recombinant Antibody; Fab Fragment (TAB-443CT-F(E)) | ELISA, FC, BL | Chimeric antibody (mouse/human) |
TAB-444CT-F(E) | Chimeric Anti-Siglec15 Recombinant Antibody; Fab Fragment (TAB-444CT-F(E)) | ELISA, FC, BL | Chimeric antibody (mouse/human) |
TAB-445CT-F(E) | Chimeric Anti-Siglec15 Recombinant Antibody; Fab Fragment (TAB-445CT-F(E)) | ELISA, FC, BL | Chimeric antibody (mouse/human) |
CAT | Product Name | Application | Type |
---|---|---|---|
MOB-0362MC | Rabbit Anti-Human SIGLEC15 Antibody | WB, IHC-P, P-ELISA |
CAT | Product Name | Application | Type |
---|---|---|---|
HPAB-0085-FY | Human Anti-SIGLEC15 Recombinant Antibody (HPAB-0085-FY) | ELISA | Human IgG2 |
HPAB-0039-WJ | Human Anti-SIGLEC15 Recombinant Antibody (HPAB-0039-WJ) | ELISA, WB | Human IgG |
HPAB-0040-WJ | Human Anti-SIGLEC15 Recombinant Antibody (HPAB-0040-WJ) | ELISA, WB | Humanized IgG |
HPAB-AP449-YC | Rat Anti-SIGLEC15 Recombinant Antibody (clone 24A3) | Inhib, FuncS | Rat IgG |
HPAB-AP450-YC | Human Anti-SIGLEC15 Recombinant Antibody (clone ch24A3) | Inhib, FuncS | Chimeric (rat/human) IgG2 |
CAT | Product Name | Application | Type |
---|---|---|---|
HPAB-0085-FY-F(E) | Human Anti-SIGLEC15 Recombinant Antibody; Fab Fragment (HPAB-0085-FY-F(E)) | ELISA | Human Fab |
HPAB-0039-WJ-F(E) | Human Anti-SIGLEC15 Recombinant Antibody; Fab Fragment (HPAB-0039-WJ-F(E)) | ELISA, WB | Human Fab |
HPAB-0040-WJ-F(E) | Human Anti-SIGLEC15 Recombinant Antibody; Fab Fragment (HPAB-0040-WJ-F(E)) | ELISA, WB | Humanized Fab |
HPAB-0916-FY-S(P) | Human Anti-SIGLEC15 Recombinant Antibody; scFv Fragment (HPAB-0916-FY-S(P)) | ELISA | Human scFv |
HPAB-0917-FY-S(P) | Human Anti-SIGLEC15 Recombinant Antibody; scFv Fragment (HPAB-0917-FY-S(P)) | ELISA | Human scFv |
There are currently no Customer reviews or questions for AFC-546CL. Click the button above to contact us or submit your feedback about this product.
View the frequently asked questions answered by Creative Biolabs Support.
For Research Use Only. Not For Clinical Use.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.